Macrophage’s role in solid tumors: two edges of a sword
Arian Jahandideh, Mahsa Yarizadeh, Maryam Noei-Khesht Masjedi, Mina Fatehnejad, Romina Jahandideh, Roben Soheili, Yeganeh Eslami, Maryam Zokaei, Ardavan Ahmadvand, Nogol Ghalamkarpour, Rajan Kumar Pandey, Mohsen Nabi‐Afjadi, Zahra Payandeh
Abstract
The tumor microenvironment is overwhelmingly dictated by macrophages, intimately affiliated with tumors, exercising pivotal roles in multiple processes, including angiogenesis, extracellular matrix reconfiguration, cellular proliferation, metastasis, and immunosuppression. They further exhibit resilience to chemotherapy and immunotherapy via meticulous checkpoint blockades. When appropriately stimulated, macrophages can morph into a potent bidirectional component of the immune system, engulfing malignant cells and annihilating them with cytotoxic substances, thus rendering them intriguing candidates for therapeutic targets. As myelomonocytic cells relentlessly amass within tumor tissues, macrophages rise as prime contenders for cell therapy upon the development of chimeric antigen receptor effector cells. Given the significant incidence of macrophage infiltration correlated with an unfavorable prognosis and heightened resistance to chemotherapy in solid tumors, we delve into the intricate role of macrophages in cancer propagation and their promising potential in confronting four formidable cancer variants-namely, melanoma, colon, glioma, and breast cancers.